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Background and Objectives: We investigated the clinical value of additional von Kossa staining in thyroid 
nodules with “suspicious for malignancy” on cytology. Materials and Methods: From March 2010 to November 
2010, 55 patients with 55 nodules which were diagnosed as “suspicious for malignancy” on cytology and had 
microcalcifications on ultrasound (US) underwent surgery and made up our final study population. We 
evaluated the role of the von Kossa stain as a preoperative diagnostic factor for thyroid cancer using 
histopathology as the “gold standard”. Diagnostic performances were calculated of the presence of psa-
mmoma bodies on both cytology and the von Kossa staining and of US in predicting thyroid cancers. Results: 
Of 55 nodules with microcalcifications on US and “suspicious for malignancy” on cytology, 53 (96.4%) were 
malignant and 2 (3.6%) were benign on histopathology. All pathologically benign nodules were negative on 
the von Kossa stain. The sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive 
value (NPV) of the von Kossa stain were 28.3%, 100%, 30.9%, 100%, and 5% for diagnosis, respectively. 
Conclusion: Von Kossa staining can be a valuable diagnostic tool in a thyroid nodule with “suspicious for 
malignancy” on cytology and microcalcifications on US, objectively.
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Introduction
Malignancy risk in thyroid nodules with “suspicious 
for malignancy” cytology has been reported to be 
60-75%.1) Lobectomy is usually recommended in 
these nodules as an initial surgical approach.2) Total 
thyroidectomy can be performed when patients have 
an increased risk for malignancy such as large tumors 
(＞4 cm), marked atypia on biopsy, a family history of 
thyroid carcinoma, and a history of radiation expo-
sure.2) Sometimes, completion thyroidectomy is need-
ed in patients who initially undergo lobectomy and are 
confirmed with a malignancy after surgery.2) 
There are several preoperative approaches to di-
agnose a malignancy in a thyroid nodule with “suspi-
cious for malignancy” cytology.3-6) Suspicious ultra-
sound (US) features are associated with malignancy 
in thyroid nodules with “suspicious for malignancy” 
cytology.3,4) If no suspicious US features are found in 
the thyroid nodules, a frozen section may help sur-
geons decide the necessary extent of surgery.6) An 
additional BRAFV600E mutation test can help decide 
whether to perform therapeutic surgery in these no-
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dules.5) Although the above additional methods can 
help surgeons determine appropriate treatment ap-
proaches, there are several limitations that occur 
when applying these various courses of treatment to 
daily practice. US assessment and frozen section are 
dependent on the performer and the molecular test is 
limited by its high expense.
Microcalcifications on US are a specific feature of 
thyroid malignancy7) and are associated with psam-
moma bodies (PBs).8) Psammoma bodies consist of 
microcrystals similar to calcium phosphate apatite cry-
stals.8) The von Kossa staining is an exceedingly in-
expensive analytic tool and can detect phosphates in 
the presence of acidic material without detecting the 
amount of calcium.9) Therefore, the von Kossa staining 
can detect malignant microcalcifications associated 
with PBs. Until now, there have been no reports eval-
uating the additional role of the von Kossa staining in 
the diagnosis of malignancies in thyroid nodules with 
“suspicious for malignancy” cytology. In this study, we 
investigated the clinical value of additional von Kossa 
staining in thyroid nodules with “suspicious for malig-
nancy” cytology.
Materials and Methods
The Institutional Review Board of Severance Hos-
pital approved this study and required neither patient 
approval nor informed consent for our review of pa-
tients’ images and records. However, written informed 
consent was obtained from all patients for US-FNA 
prior to each procedure as part of daily practice.
Study Population
Since 2006, our institutional registry has collected 
data on numerous patients including all patients with 
thyroid nodules who underwent US-FNAs at our 
institution. Using the registry, data was retrieved for 
patients with “suspicious for malignancy” cytologic re-
sults from March 2010 to November 2010 at our 
institution. There were 252 nodules in 247 patients 
which were diagnosed as “suspicious for malignancy” 
on cytology. Seventy four nodules in 74 patients had 
microcalcifications with or without macrocalcifications 
on US. Among them, 55 patients with 55 nodules un-
derwent surgery and made up our final study popu-
lation. The mean age of the patients was 48.2 years 
(range, 17-76 years). The mean lesion size of the 
thyroid nodules was 8.9 mm (range, 3-50 mm). 
Imaging Evaluation 
US images were obtained using a 5- to 12-MHz 
linear array transducer (iU22; Philips Medical Systems, 
Bothell, WA, USA) for evaluation of thyroid nodules by 
one of 8 board- certificated radiologists specializing in 
thyroid imaging and were assigned arbitrarily according 
to the hospital’s daily schedule. Compound imaging 
was performed in all cases. All US-FNAs were per-
formed by the same radiologist who performed the US 
examination. The nodule size was defined as the larg-
est diameter on US. US features of all thyroid nodules 
that underwent US-FNAs were prospectively re-
corded by the previously described methods.10) 
US-Guided Fine Needle Aspiration (US-FNA)
US-FNA was performed by the same radiologist 
who performed US. US-FNA was performed with a 
23-gauge needle attached to a 2 mL disposable 
plastic syringe and each lesion was aspirated at least 
twice with the freehand technique. Obtained samples 
were expelled on glass slides, smeared, and placed 
immediately in 95% alcohol for Papanicolaou staining. 
The remaining material in the syringe was rinsed in 
saline for cell block processing. Cytopathologists were 
not on site during the aspiration procedure and cytol-
ogy slides were interpreted to confirm the cytologic di-
agnosis by an experienced pathologist. Based on the 
Bethesda System for Reporting Thyroid Cytopathology, 
FNA cytology results were classified as non-diag-
nostic, benign, atypia undetermined significance/follicular 
lesion of undetermined significance (AUS/FLUS), sus-
picious for follicular neoplasm or suspicious for a 
Hurthle cell neoplasm, suspicious for malignancy and 
malignancy.1) 
Cytology and Surgical Pathology
Cytology smears for each case were reviewed to 
assess the presence of calcifications by light micro-
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Fig. 1. Two types of calcifications on cytologic slides. (A) “Psammoma bodies” showing calcified concentric rings (smear, 
Papanicolaou stain, ×400). (B) “Dystrophic calcifications” showing irregular plates (smear, Papanicolaou stain, ×200).
scopy. Calcifications were divided into PBs and dys-
trophic calcifications (Fig. 1) by an experienced cyto-
pathologist (H.J.K.) who was always unaware of the fi-
nal pathologic results. When a nodule had dystrophic 
calcifications as well as PBs, we listed it as PBs. 
Subsequently, the cover slides were removed by xy-
lene and rehydrated using xylene, decreased grades 
of ethanol and deionized water. The uncovered slides 
were stained by von Kossa. The slides were incu-
bated with an aqueous solution of 5% silver nitrate for 
60 minutes at room temperature under sunlight until 
they took on a dark brown color. Following a distilled 
water rinse, the slides were incubated with a 5% so-
dium thiosulfate solution for 5 minutes. Calcium salts 
were often stained black or brown-black. 
Total thyroidectomy was performed in 35 patients, 
ipsilateral total and contralateral subtotal thyroidectomy 
in 2, and lobectomy in 18. In our institution, surgical 
specimens were fixed in 10% formalin and cut at 3- 
mm intervals.11) All suspicious lesions and surrounding 
tissues were embedded in paraffin wax and stained 
with Hematoxylin and Eosin for histological exami-
nation. The presence of calcifications, including the 
presence of PBs, dystrophic calcifications, or ossifica-
tions was determined from surgical slides. When a 
nodule had dystrophic calcifications or ossifications as 
well as PBs, we listed it as with PBs. All these proc-
esses were performed by an experienced cytopathol-
ogist (H.J.K.) who was always unaware of the final 
pathologic result of each case.
Data and Statistical Analysis
We evaluated the role of the von Kossa stain as a 
preoperative diagnostic factor for thyroid cancer using 
histopathology as the “gold standard”. Patients with 
benign or malignant thyroid nodules were compared 
according to gender, and the results of the von Kossa 
stain, using the Fisherʼs exact test. Values with a 
skewed distribution were logarithmically transformed 
and analyzed. The normality of the variables was test-
ed using the Kolmogorov-Smirnov test. An indepen-
dent two-sample t test was used to compare patient 
age and size between benign and malignant nodules. 
When size was not normally distributed, a nonpara-
metric method such as the Mann-Whitney U test was 
used. The sensitivity, specificity, accuracy, positive 
predictive value (PPV) and negative predictive value 
(NPV) of the presence of a PB on both cytology and 
von Kossa staining and US in predicting thyroid can-
cers were calculated. Statistical significance was as-
signed to p values＜0.05. Data were analyzed using 
SAS software (SAS System for Windows, version 
9.1.3; SAS Institute, Cary, NC, USA).
Results
Of 55 nodules with microcalcifications on US and 
suspicious for malignancy on cytology, 53 (96.4%) 
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Table 1. Demographics of the 55 patients
Characteristics Total (n=55) Malignancy (n=53) Benignity (n=2)
Age (years, mean±SD) 48.2±12.5 47.6±12.2 65.5±0.7
Size (mm, median, range) 9 (3-50) 8.5 (5-12)
Gender
   Male 6 (10.9%) 6 (11.3%) 0 (0%)
   Female 49 (89.1%) 47 (88.7%) 2 (100%)
Cytology slide calcification
   Positive 17 (30.9%) 17 (32.1%) 0 (0%)
   Negative 38 (69.1%) 36 (67.9%) 2 (100%)
PBs on cytology slides
   Positive 13 (23.6%) 13 (24.5%) 0 (0%)
   Negative 42 (76.4%) 40 (75.5%) 2 (100%)
von Kossa stain
   Positive 15 (27.3%) 15 (28.3%) 0 (0%)
   Negative 40 (72.7%) 38 (71.7%) 2 (100%)
PBs on pathology slides
   Positive 32 (58.2%) 32 (41.5%) 0 (0%)
   Negative 23 (41.8%) 21 (41.5%) 2 (100%)
PBs: psammoma bodies, SD: standard deviation
Table 2. Final histopathologic diagnosis 
Final Pathology No (%) PBs on cytology slides
Positive on the 
von Kossa stain
PBs on 
pathology slides
Malignant 
  (n=53, 96.4%)
Papillary carcinoma, conventional 49 (92.5%) 12 13 30
Papillary carcinoma, FV 2 (3.8%) 0 1 0
Papillary carcinoma, DSV 1 (1.9%) 1 1 1
Medullary carcinoma 1 (1.9%) 0 0 1
Benign (n=2, 3.6%) Adenomatous hyperplasia 2 (100%) 0 0 0
DSV: diffuse sclerosing variant, FV: follicular variant, PBs: psammoma bodies
were malignant and 2 (3.6%) were benign on histo-
pathology (Table 1). The mean age was 48.2 (range, 
23-72) years. Patients with benign thyroid nodules 
were significantly older than ones with malignant thy-
roid nodules (p＜0.001). There was no significant dif-
ference in nodule size and gender between the be-
nign and malignant groups. The histopathology results 
are summarized in Table 2. The 12 papillary thyroid 
cancers (PTCs) (24.5%, 12/49) showed PBs on cyto-
logic slides and none of the 2 cases of the follicular 
variant of PTCs showed PBs on cytologic slides.
On cytologic slides, 17 (30.9%, 17/55) nodules 
showed calcifications, of which 11 nodules had PBs, 
4 had dystrophic calcifications, and 2 had both PBs 
and dystrophic calcifications. The sensitivity, specificity, 
accuracy, positive predictive value (PPV), and neg-
ative predictive value (NPV) of PBs on cytology slides 
for predicting malignancy were 24.5%, 100%, 27.3%, 
100%, and 4.5%, respectively. There were 15 nodules 
which were positive on the von Kossa stain that were 
also confirmed as malignant (13 PTCs) 1 follicular var-
iant type of PTC, and 1 diffuse sclerosing variant type 
of PTC) on histopathology (Fig. 2). All pathologically 
benign nodules were negative on the von Kossa stain. 
The sensitivity, specificity, accuracy, positive predictive 
value (PPV), and negative predictive value (NPV) of 
the von Kossa stain for diagnosis were 28.3%, 100%, 
30.9%, 100%, and 5%, respectively.
We examined the surgical specimens, specifically 
searching for the presence of calcifications. Calcificati-
ons were found in 44 (80%) of 55 nodules, including 
PBs (n=32), dystrophic calcifications (n=9), and heter-
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Fig. 2. A 23-year-old female diagnosed with papillary thyroid carcinoma. A 5-cm hypoechogenic mass with internal micro-
calcifications was seen on (A, left-transverse scan, right-longitudinal scan) the right-longitudinal scan. On the cytology smear, 
there was a crowded group of follicular epithelial cells with powdery chromatin, nuclear grooves and micronucleoli, which were
interpreted as “suspicious for papillary thyroid carcinoma” (B, smear, Papanicolaou stain, ×400). Psammoma bodies were seen
in cytologic slides and the von Kossa stain was positive (C, arrow, smear, ×400). On the surgical slide, psammoma bodies 
were associated with tumor cells (D, arrow, ×400).
otopic ossifications (n=3). Among nodules with PBs on 
pathologic slides which were all confirmed as cancers 
on pathology, 17 (46.9%, 15/32) showed calcifications 
on cytologic slides and 13 (40.6%, 13/32) were pos-
itive on the von Kossa stain. Among 9 nodules with 
dystrophic calcifications on surgical slides, 2 (22.2%, 
2/9) showed calcifications on cytologic slides. One 
showed both a PB and dystrophic calcifications and 
1 showed dystrophic calcifications on cytologic slides. 
These were positive on the von Kossa stain. All 3 
cancers (2 PTCs and 1 follicular variant type of PTC) 
with heterotopic ossifications on surgical slides were 
negative on the von Kossa stain. There were no cal-
cifications found in 11 nodules (20%) positive on the 
von Kossa stain even though preoperative US show-
ed microcalcifications. 
Discussion
We found that all thyroid nodules with “suspicious 
for malignancy” cytology and with positive von Kossa 
stains were confirmed as cancers. All nodules with 
positive von Kossa stains were cancers, suggesting a 
100% PPV. Of the 38 malignant thyroid nodules, 15 
nodules had positive von Kossa stains, resulting in a 
28.3% sensitivity. The von Kossa stain was first de-
scribed as a “silver nitrate method for calcium deposits” 
by von Kossa,12) and was modified afterwards.13,14) In 
the staining process, silver ions react with phosphate 
in the presence of acidic material and do not react 
with calcium.9) 
Psammoma bodies are 50-70 μm round-shaped 
calcific concretions which are concentrically laminated.15) 
They have been thought to arise from thickening of 
the base lamina of the vascular stalk of neoplastic 
papillae, followed by vascular thrombosis, calcification, 
and tumor cell necrosis and necrosis and calcification 
in intralymphatic tumor thrombi.15) Psammoma bodies 
can be seen in various conditions such as papillary 
neoplasms of various organs, endometriosis, hyper-
plastic nodular goiter, or lymphocytic thyroiditis.16-18) 
For diagnosing a thyroid malignancy, PBs are not com-
mon findings (0-25%) on cytology and PBs alone 
cannot be a reliable characteristic of malignancy with-
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out other typical cytologic features.19) Also, itʼs not easy 
to differentiate PBs from other calcifications in daily 
practice due to their small size, natural continuum, and 
the two-dimensionality of cytology slides.20) In this 
study, 13 nodules which had “suspicious for malig-
nancy” cytology results and had PBs observed on 
cytologic slides were confirmed as cancer. This result 
is similar to a previous report which concluded that 
thyroid cancers can be reliably diagnosed when cyto-
logic features included PBs with other cytologic fea-
tures such as papillary fonds, nuclear grooves, and 
intranuclear inclusions.20) 
Microcalcifications on US can be correlated with 
pathologic concretions including PBs, dystrophic cal-
cifications, and inspissated colloids. Therefore, all nod-
ules with microcalcifications on US were not confirmed 
as cancers although the risk of malignancy may be 
high in these nodules.3) In this study, the malignant 
rate was exceedingly high at 96.4% in thyroid nodules 
with microcalcifications on US and “suspicious for ma-
lignancy” on cytologic results, compared with the risk 
of malignancy found for thyroid nodules with “suspi-
cious for malignancy” on cytologic results according 
to the Bethesda System for Reporting Thyroid Cyto-
pathology (BSRTC).1) Pathologically, PBs are lamellated 
structures which sets them apart from dystrophic cal-
cifications and inspissated colloids. Also, dystrophic 
calcifications are of irregular shape and inspissated 
colloids do not have calcifications.20) Although PBs on 
cytology slides showed a 100% PPV for diagnosing 
malignancy in this study, inherent limitations of cyto-
logic interpretations might result in different diagnostic 
performances in other situations. Therefore, we eval-
uated the role of additional von Kossa staining which 
can detect phosphate in the presence of acidic mate-
rial without detecting calcium.9) The specificity and 
PPV of the von Kossa staining for diagnosing malig-
nancy were both 100%, in contrast to lower sensitivity 
and NPV. Considering the subjective nature of inter-
preting cytologic slides and its inherent limitation, the 
von Kossa staining can lead to a definite diagnosis in 
thyroid nodules with “suspicious for malignancy” cy-
tology and microcalcifications on US, objectively.
Some limitations might be an issue in this study. 
First, this is a retrospective study and included 55 pa-
tients who underwent surgery, which is a relatively 
small sample size, resulting in inevitable selection bias. 
Second, US and cytology results were interpreted by 
several radiologists and cytopathologists. Therefore, 
there may be interobserver variabilities in the assess-
ment of US findings and cytology of thyroid nodules, 
respectively.21,22) Future studies should be performed 
in other institutions to verify our results.
Conclusion
From the preceding discussion, we conclude that 
the von Kossa staining can be a valuable diagnostic 
tool in a thyroid nodule with “suspicious for malignancy” 
cytology and microcalcifications on US, objectively.
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